Georgios Chamilos

Also affiliated with FORTH Institute of Molecular Biology and Biotechnology, Institute of Molecular Biology and Biotechnology, University Hospital of Heraklion, Hella (Germany)

MedicineImmunology and MicrobiologyVeterinaryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?”.

Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1079

N/A

0DataRank · unranked

29 citations

Michail S. Lionakis, Dimitrios P. Kontoyiannis, Georgios Chamilos

Mucoricin is a Ricin-Like Toxin that is Critical for the Pathogenesis of Mucormycosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.13.426274

N/A

0DataRank · unranked

11 citations

Clara Baldin, Yiyou Gu, Shakti Singh, Teclegiorgis Gebremariam, Marc Swidergall +16 more

BTK drives neutrophil activation for sterilizing antifungal immunity

Journal of Clinical Investigation(2024)10.1172/jci176142

N/A

0DataRank · unranked

29 citations

Marissa A. Zarakas, Andrew Wishart, Mark Roschewski, Mariano A. Aufiero, Ágnes Donkó +23 more